Christopher Moxham serves as Executive at Fulcrum Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Christopher Moxham has executed 4 insider transactions totaling $911.4K, demonstrating a bearish approach to their equity position. Their most recent transaction on Aug 10, 2021 involved exercising options for 20,714 shares valued at $162.4K.
Christopher Moxham currently holds 20,714 shares of Fulcrum Therapeutics, Inc. (FULC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher Moxham has been a net seller of FULC stock. They have purchased $0 and sold $911.4K worth of shares.
Christopher Moxham's most recent insider trade was on Aug 10, 2021, when they sold 20,714 shares at $7.84 per share.
Get notified when new Form 4 filings are submitted
| $17.00 |
| Discretionary |
| Aug 10, 2021 | FULC | $243.6K | Option Exercise | 31,071 | $7.84 | Discretionary |
| Aug 10, 2021 | FULC | $559.3K | Sale | 31,071 | $18.00 | Discretionary |